Informations

Stand number

C76

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

Development of methods to prepare exosomes from Vdelta2-T cells for treating EBV-associated cancers. They selectively kill tumor cells and activate T-cell antitumor immunity, offering a stable, scalable, and safer option for cancer therapy.

Simplified description

Researchers are developing a new cancer treatment using tiny particles called exosomes from immune cells. These exosomes can target and kill cancer cells linked to EBV while boosting the body's natural defenses. This method is safe, effective, and can be easily scaled for treatment.